10-Year hip implant study aims to prove Long-Lasting relief

NCT ID NCT04123431

Recruiting now Disease control Sponsor: JRI Orthopaedics Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study follows 225 people who have had a total hip replacement using the JRI ACE cup system. Over 10 years, researchers will track pain, function, and implant survival through questionnaires and X-rays. The goal is to make sure the device stays safe and works well over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ACE Acetabular Cup System (hip replacement device)
What this could lead to: If successful, this study will confirm that the ACE cup system is safe and effective for long-term hip replacement, helping surgeons choose the best option for patients.
What could go wrong: This is an observational follow-up study, not a test of a new treatment. It cannot prove the device works better than others, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP DISEASE

Contacts and locations

Locations

University Hospitals Sussex NHS Foundation Trust
RECRUITING

Worthing, BN11 2DH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.